Pharmaceutical giant AbbVie Inc. (ABBV) shares came under pressure as the market closed on Friday, following the disappointing first quarter sales performance of the company's arthritis drug, Humira. The company forecast that Humira's sales could slow further in the face of heightened competition.…
#abbvieinc #abbv #humira #yahoofinance #anjaleekhemlani #angelsmith
Continue reading...